Parkside Investments LLC purchased a new position in shares of Albemarle Corporation (NYSE:ALB) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,800 shares of the specialty chemicals company’s stock, valued at approximately $245,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. lifted its holdings in Albemarle Corporation by 2.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock valued at $102,000 after acquiring an additional 20 shares during the period. Thompson Davis & CO. Inc. lifted its holdings in Albemarle Corporation by 650.0% in the third quarter. Thompson Davis & CO. Inc. now owns 750 shares of the specialty chemicals company’s stock valued at $102,000 after acquiring an additional 650 shares during the period. Carroll Financial Associates Inc. lifted its holdings in Albemarle Corporation by 0.3% in the second quarter. Carroll Financial Associates Inc. now owns 982 shares of the specialty chemicals company’s stock valued at $103,000 after acquiring an additional 3 shares during the period. Smithfield Trust Co. lifted its holdings in Albemarle Corporation by 16.1% in the second quarter. Smithfield Trust Co. now owns 1,008 shares of the specialty chemicals company’s stock valued at $106,000 after acquiring an additional 140 shares during the period. Finally, Highlander Capital Management LLC acquired a new stake in Albemarle Corporation in the second quarter valued at $106,000. 86.64% of the stock is owned by hedge funds and other institutional investors.

In other Albemarle Corporation news, EVP Matthew Juneau sold 5,397 shares of Albemarle Corporation stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $115.77, for a total value of $624,810.69. Following the completion of the sale, the executive vice president now owns 360 shares in the company, valued at approximately $41,677.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Karen G. Narwold sold 11,500 shares of Albemarle Corporation stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $115.95, for a total value of $1,333,425.00. Following the completion of the sale, the executive vice president now owns 36,620 shares of the company’s stock, valued at approximately $4,246,089. The disclosure for this sale can be found here. Company insiders own 0.74% of the company’s stock.

WARNING: This report was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/11/13/parkside-investments-llc-takes-245000-position-in-albemarle-corporation-alb.html.

Albemarle Corporation (NYSE ALB) traded down $0.22 during trading on Monday, reaching $140.62. The company had a trading volume of 1,056,300 shares, compared to its average volume of 1,173,828. The stock has a market cap of $15,537.89, a PE ratio of 34.81, a PEG ratio of 2.14 and a beta of 1.72. Albemarle Corporation has a 1 year low of $76.32 and a 1 year high of $144.99. The company has a current ratio of 2.11, a quick ratio of 1.56 and a debt-to-equity ratio of 0.35.

Albemarle Corporation (NYSE:ALB) last posted its quarterly earnings data on Wednesday, November 8th. The specialty chemicals company reported $1.08 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.01. The firm had revenue of $755.00 million during the quarter, compared to analysts’ expectations of $732.19 million. Albemarle Corporation had a return on equity of 11.61% and a net margin of 30.07%. The firm’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.91 EPS. equities research analysts predict that Albemarle Corporation will post 4.45 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Friday, December 15th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date of this dividend is Thursday, December 14th. Albemarle Corporation’s dividend payout ratio is presently 16.56%.

A number of equities research analysts have commented on ALB shares. BidaskClub downgraded Albemarle Corporation from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Royal Bank Of Canada reissued a “buy” rating and issued a $136.00 target price on shares of Albemarle Corporation in a report on Wednesday, September 20th. Instinet raised their target price on Albemarle Corporation from $134.00 to $146.00 and gave the company a “buy” rating in a report on Monday, September 18th. KeyCorp reissued a “buy” rating and issued a $125.00 target price on shares of Albemarle Corporation in a report on Sunday, September 3rd. Finally, Jefferies Group LLC set a $144.00 target price on Albemarle Corporation and gave the company a “buy” rating in a report on Monday, August 21st. Eight analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Albemarle Corporation presently has an average rating of “Buy” and a consensus target price of $128.15.

About Albemarle Corporation

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle Corporation (NYSE:ALB)

Receive News & Stock Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related stocks with our FREE daily email newsletter.